NO20000860D0 - Syklopeptidderivater som adhesjonsinhibitorer - Google Patents

Syklopeptidderivater som adhesjonsinhibitorer

Info

Publication number
NO20000860D0
NO20000860D0 NO20000860A NO20000860A NO20000860D0 NO 20000860 D0 NO20000860 D0 NO 20000860D0 NO 20000860 A NO20000860 A NO 20000860A NO 20000860 A NO20000860 A NO 20000860A NO 20000860 D0 NO20000860 D0 NO 20000860D0
Authority
NO
Norway
Prior art keywords
adhesion inhibitors
cyclopeptide derivatives
cyclopeptide
derivatives
inhibitors
Prior art date
Application number
NO20000860A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000860L (no
Inventor
Guenter Hoelzemann
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20000860L publication Critical patent/NO20000860L/no
Publication of NO20000860D0 publication Critical patent/NO20000860D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20000860A 1997-08-23 2000-02-22 Syklopeptidderivater som adhesjonsinhibitorer NO20000860D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19736772A DE19736772A1 (de) 1997-08-23 1997-08-23 Cyclopeptidderivate
PCT/EP1998/005161 WO1999010371A2 (de) 1997-08-23 1998-08-14 Cyclopeptidderivate als adhäsionsinhibitoren

Publications (2)

Publication Number Publication Date
NO20000860L NO20000860L (no) 2000-02-22
NO20000860D0 true NO20000860D0 (no) 2000-02-22

Family

ID=7839977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000860A NO20000860D0 (no) 1997-08-23 2000-02-22 Syklopeptidderivater som adhesjonsinhibitorer

Country Status (18)

Country Link
EP (1) EP1007545A2 (zh)
JP (1) JP2001514186A (zh)
KR (1) KR20010022828A (zh)
CN (1) CN1267306A (zh)
AR (1) AR013650A1 (zh)
AU (1) AU734829B2 (zh)
BR (1) BR9811992A (zh)
CA (1) CA2301182A1 (zh)
DE (1) DE19736772A1 (zh)
HU (1) HUP0003500A3 (zh)
ID (1) ID23952A (zh)
NO (1) NO20000860D0 (zh)
PL (1) PL341090A1 (zh)
RU (1) RU2200166C2 (zh)
SK (1) SK2132000A3 (zh)
TW (1) TW477793B (zh)
WO (1) WO1999010371A2 (zh)
ZA (1) ZA987558B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
JPH07316193A (ja) * 1994-05-24 1995-12-05 Asahi Glass Co Ltd ペプチド誘導体およびその用途

Also Published As

Publication number Publication date
NO20000860L (no) 2000-02-22
HUP0003500A3 (en) 2001-12-28
ZA987558B (en) 1999-02-23
HUP0003500A2 (hu) 2001-02-28
PL341090A1 (en) 2001-03-26
AR013650A1 (es) 2001-01-10
AU9531998A (en) 1999-03-16
DE19736772A1 (de) 1999-02-25
AU734829B2 (en) 2001-06-21
ID23952A (id) 2000-06-08
CN1267306A (zh) 2000-09-20
TW477793B (en) 2002-03-01
BR9811992A (pt) 2000-09-05
CA2301182A1 (en) 1999-03-04
WO1999010371A2 (de) 1999-03-04
RU2200166C2 (ru) 2003-03-10
JP2001514186A (ja) 2001-09-11
KR20010022828A (ko) 2001-03-26
WO1999010371A3 (de) 1999-05-27
EP1007545A2 (de) 2000-06-14
SK2132000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO986090D0 (no) Fenylalaninderivater som integrininhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO980467D0 (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
DK0818448T3 (da) Cycloalkanopyridiner som CETP-inhibitorer
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO992821D0 (no) Ketobenzamider som calpain-inhibitorer
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
FI951001A (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
NO985874D0 (no) Bestemte fosfinylderivater nyttige som naaladase inhibitorer
NO20002958D0 (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK1218383T3 (da) Biocykliske imidazo-5-yl-aminoderivater
NO991384D0 (no) Substituerte heterocykler som anti-tumormidler
ATE224402T1 (de) Cyclische adhäsionsinhibitoren
DK1007512T3 (da) Forgrenede alkoxysubstituerede 2-aminopyridiner som NOS-inhibitorer
NO20006227D0 (no) Tetrahydroquiolinderivater som glycin antagonister
DE69811367D1 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653D0 (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
FI951002A (fi) Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina
FI971590A0 (fi) Anordning foer foerdelning av inluft till rumsutrymmen som skall luftkonditioneras
NO20000094D0 (no) 6-Azaurcilderivater som IL-5 inhibitorer